dapi mounting medium Search Results


98
Vector Laboratories vectashield mounting medium with dapi
Vectashield Mounting Medium With Dapi, supplied by Vector Laboratories, used in various techniques. Bioz Stars score: 98/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/vectashield mounting medium with dapi/product/Vector Laboratories
Average 98 stars, based on 1 article reviews
vectashield mounting medium with dapi - by Bioz Stars, 2026-03
98/100 stars
  Buy from Supplier

94
Novus Biologicals dapi
Dapi, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/dapi/product/Novus Biologicals
Average 94 stars, based on 1 article reviews
dapi - by Bioz Stars, 2026-03
94/100 stars
  Buy from Supplier

96
Vector Laboratories dapi
Dapi, supplied by Vector Laboratories, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/dapi/product/Vector Laboratories
Average 96 stars, based on 1 article reviews
dapi - by Bioz Stars, 2026-03
96/100 stars
  Buy from Supplier

95
Santa Cruz Biotechnology ultracruztm mounting medium
Ultracruztm Mounting Medium, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/ultracruztm mounting medium/product/Santa Cruz Biotechnology
Average 95 stars, based on 1 article reviews
ultracruztm mounting medium - by Bioz Stars, 2026-03
95/100 stars
  Buy from Supplier

96
Vector Laboratories vectashield vibrance antifade mounting medium with dapi
a. Left - Representative images of EU (red) and <t>DAPI</t> (Blue) staining, in scr and shp53 cells. Right - quantification of nuclear EU intensity per cell in Scr (101±40; n=383) and shp53 cells (173±76; n=398). EU distribution is divided to tertiaries. The data are representative of three independent experiments with similar results. Statistical analysis was performed using the student’s t-test. b. Left - Representative images of γH2AX (green), EU (red), nuclei (blue) in the same nucleus. Right – Quantification of γH2AX foci in scr (mean foci/cells 1.9; n=383), shp53 (4.1; n=398) and in each tertial of shp53 distribution as shown in A. The mean foci per nucleus in the low (0.5; n=132), mid (3.0; n=132), high (8.7; n=133) tertial. c. Transcription levels quantified using nuclear EU intensity and normalized to scr mean for scr cells (1±0.3; n=708), shp53 cells (1.37±0.3; n=731) and shp53 cells treated with 10-15 μM DRB for 48 hours (1.1±0.4; n=392) or treated with 10ng/ml ActD for 3 hours (1±0.1; n=304). The data are representative of two independent experiments with similar results. Statistical analysis was performed using one-Way Anova test. d. Percentage of nuclei with the indicated number of γH2AX foci for Scr (mean foci/cells 1.9; n=791), shp53 (4.4; n=831), shp53 + 10-15 μM DRB for 48 hours (1.6; n=696) and shp53 + 10ng/ml ActD for 3 hours (1.9; n=769). The data are a summary of two independent experiments. Statistical analysis was performed using Mann Whitney rank-sum test done on the distribution. e. Percentage of cells with the indicated number of micronuclei with the same conditions as d, number of analyzed cells per condition; Scr (n=1126), shp53 (n=1076), shp53 + 10-15 μM DRB for 48 hours (n=945) and shp53 + 10ng/ml ActD for 3 hours (n=934). The Chi-Square test of Independence was performed to compare the distribution of cells with micronuclei between each condition. f. Heatmap representation of log fold changes (log FC) in metabolite levels analyzed using LC-MC in scr, shp53 and shp53 cells treated with 50 μM AUGC for 48 hours, 15 μM DRB for 48 hours or 10ng/ml ActD for 3 hours. The comparisons are shown in the columns (appear at the top of the panel) and include six biological repeats for each condition. In all comparisons the same shp53 data was used. Green - increased metabolite levels compared to the indicated condition. Red - decreased metabolite levels compared to the indicated condition. P-value for each comparison calculated using one-sided t-test and indicated in each box (*p < 0.05, **p < 0.01, the value <0.1 is indicated). g. Hypertranscription fold-change (re-analysis of the TCGA cohort from the study by Zatzman et al.) shown for two groups: WT TP53/MDM2 (mean ± SEM: 2 ± 0.04, n=2273) and TP53-/MDM2+ (mean ± SEM: 2.33 ± 0.03, n=4032). Each circle represents a tumor sample, with the total number of samples per group indicated on the plot. Data are presented as mean ± SEM. Statistical significance was assessed using a non-parametric t-test (Mann-Whitney test) to compare two independent groups, as the data were not normally distributed. P-values less than 0.05 were considered statistically significant (*p < 0.05, **p < 0.01, ***p < 0.001, **p < 0.0001).
Vectashield Vibrance Antifade Mounting Medium With Dapi, supplied by Vector Laboratories, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/vectashield vibrance antifade mounting medium with dapi/product/Vector Laboratories
Average 96 stars, based on 1 article reviews
vectashield vibrance antifade mounting medium with dapi - by Bioz Stars, 2026-03
96/100 stars
  Buy from Supplier

98
Abcam 6 diamidino e phenylindole
a. Left - Representative images of EU (red) and <t>DAPI</t> (Blue) staining, in scr and shp53 cells. Right - quantification of nuclear EU intensity per cell in Scr (101±40; n=383) and shp53 cells (173±76; n=398). EU distribution is divided to tertiaries. The data are representative of three independent experiments with similar results. Statistical analysis was performed using the student’s t-test. b. Left - Representative images of γH2AX (green), EU (red), nuclei (blue) in the same nucleus. Right – Quantification of γH2AX foci in scr (mean foci/cells 1.9; n=383), shp53 (4.1; n=398) and in each tertial of shp53 distribution as shown in A. The mean foci per nucleus in the low (0.5; n=132), mid (3.0; n=132), high (8.7; n=133) tertial. c. Transcription levels quantified using nuclear EU intensity and normalized to scr mean for scr cells (1±0.3; n=708), shp53 cells (1.37±0.3; n=731) and shp53 cells treated with 10-15 μM DRB for 48 hours (1.1±0.4; n=392) or treated with 10ng/ml ActD for 3 hours (1±0.1; n=304). The data are representative of two independent experiments with similar results. Statistical analysis was performed using one-Way Anova test. d. Percentage of nuclei with the indicated number of γH2AX foci for Scr (mean foci/cells 1.9; n=791), shp53 (4.4; n=831), shp53 + 10-15 μM DRB for 48 hours (1.6; n=696) and shp53 + 10ng/ml ActD for 3 hours (1.9; n=769). The data are a summary of two independent experiments. Statistical analysis was performed using Mann Whitney rank-sum test done on the distribution. e. Percentage of cells with the indicated number of micronuclei with the same conditions as d, number of analyzed cells per condition; Scr (n=1126), shp53 (n=1076), shp53 + 10-15 μM DRB for 48 hours (n=945) and shp53 + 10ng/ml ActD for 3 hours (n=934). The Chi-Square test of Independence was performed to compare the distribution of cells with micronuclei between each condition. f. Heatmap representation of log fold changes (log FC) in metabolite levels analyzed using LC-MC in scr, shp53 and shp53 cells treated with 50 μM AUGC for 48 hours, 15 μM DRB for 48 hours or 10ng/ml ActD for 3 hours. The comparisons are shown in the columns (appear at the top of the panel) and include six biological repeats for each condition. In all comparisons the same shp53 data was used. Green - increased metabolite levels compared to the indicated condition. Red - decreased metabolite levels compared to the indicated condition. P-value for each comparison calculated using one-sided t-test and indicated in each box (*p < 0.05, **p < 0.01, the value <0.1 is indicated). g. Hypertranscription fold-change (re-analysis of the TCGA cohort from the study by Zatzman et al.) shown for two groups: WT TP53/MDM2 (mean ± SEM: 2 ± 0.04, n=2273) and TP53-/MDM2+ (mean ± SEM: 2.33 ± 0.03, n=4032). Each circle represents a tumor sample, with the total number of samples per group indicated on the plot. Data are presented as mean ± SEM. Statistical significance was assessed using a non-parametric t-test (Mann-Whitney test) to compare two independent groups, as the data were not normally distributed. P-values less than 0.05 were considered statistically significant (*p < 0.05, **p < 0.01, ***p < 0.001, **p < 0.0001).
6 Diamidino E Phenylindole, supplied by Abcam, used in various techniques. Bioz Stars score: 98/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/6 diamidino e phenylindole/product/Abcam
Average 98 stars, based on 1 article reviews
6 diamidino e phenylindole - by Bioz Stars, 2026-03
98/100 stars
  Buy from Supplier

93
Santa Cruz Biotechnology counterstain 4
a. Left - Representative images of EU (red) and <t>DAPI</t> (Blue) staining, in scr and shp53 cells. Right - quantification of nuclear EU intensity per cell in Scr (101±40; n=383) and shp53 cells (173±76; n=398). EU distribution is divided to tertiaries. The data are representative of three independent experiments with similar results. Statistical analysis was performed using the student’s t-test. b. Left - Representative images of γH2AX (green), EU (red), nuclei (blue) in the same nucleus. Right – Quantification of γH2AX foci in scr (mean foci/cells 1.9; n=383), shp53 (4.1; n=398) and in each tertial of shp53 distribution as shown in A. The mean foci per nucleus in the low (0.5; n=132), mid (3.0; n=132), high (8.7; n=133) tertial. c. Transcription levels quantified using nuclear EU intensity and normalized to scr mean for scr cells (1±0.3; n=708), shp53 cells (1.37±0.3; n=731) and shp53 cells treated with 10-15 μM DRB for 48 hours (1.1±0.4; n=392) or treated with 10ng/ml ActD for 3 hours (1±0.1; n=304). The data are representative of two independent experiments with similar results. Statistical analysis was performed using one-Way Anova test. d. Percentage of nuclei with the indicated number of γH2AX foci for Scr (mean foci/cells 1.9; n=791), shp53 (4.4; n=831), shp53 + 10-15 μM DRB for 48 hours (1.6; n=696) and shp53 + 10ng/ml ActD for 3 hours (1.9; n=769). The data are a summary of two independent experiments. Statistical analysis was performed using Mann Whitney rank-sum test done on the distribution. e. Percentage of cells with the indicated number of micronuclei with the same conditions as d, number of analyzed cells per condition; Scr (n=1126), shp53 (n=1076), shp53 + 10-15 μM DRB for 48 hours (n=945) and shp53 + 10ng/ml ActD for 3 hours (n=934). The Chi-Square test of Independence was performed to compare the distribution of cells with micronuclei between each condition. f. Heatmap representation of log fold changes (log FC) in metabolite levels analyzed using LC-MC in scr, shp53 and shp53 cells treated with 50 μM AUGC for 48 hours, 15 μM DRB for 48 hours or 10ng/ml ActD for 3 hours. The comparisons are shown in the columns (appear at the top of the panel) and include six biological repeats for each condition. In all comparisons the same shp53 data was used. Green - increased metabolite levels compared to the indicated condition. Red - decreased metabolite levels compared to the indicated condition. P-value for each comparison calculated using one-sided t-test and indicated in each box (*p < 0.05, **p < 0.01, the value <0.1 is indicated). g. Hypertranscription fold-change (re-analysis of the TCGA cohort from the study by Zatzman et al.) shown for two groups: WT TP53/MDM2 (mean ± SEM: 2 ± 0.04, n=2273) and TP53-/MDM2+ (mean ± SEM: 2.33 ± 0.03, n=4032). Each circle represents a tumor sample, with the total number of samples per group indicated on the plot. Data are presented as mean ± SEM. Statistical significance was assessed using a non-parametric t-test (Mann-Whitney test) to compare two independent groups, as the data were not normally distributed. P-values less than 0.05 were considered statistically significant (*p < 0.05, **p < 0.01, ***p < 0.001, **p < 0.0001).
Counterstain 4, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/counterstain 4/product/Santa Cruz Biotechnology
Average 93 stars, based on 1 article reviews
counterstain 4 - by Bioz Stars, 2026-03
93/100 stars
  Buy from Supplier

94
OriGene fluorescent mounting media with dapi
KEY RESOURCES TABLE
Fluorescent Mounting Media With Dapi, supplied by OriGene, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/fluorescent mounting media with dapi/product/OriGene
Average 94 stars, based on 1 article reviews
fluorescent mounting media with dapi - by Bioz Stars, 2026-03
94/100 stars
  Buy from Supplier

93
OriGene dapi e19 100 gbi labs bothell wa
KEY RESOURCES TABLE
Dapi E19 100 Gbi Labs Bothell Wa, supplied by OriGene, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/dapi e19 100 gbi labs bothell wa/product/OriGene
Average 93 stars, based on 1 article reviews
dapi e19 100 gbi labs bothell wa - by Bioz Stars, 2026-03
93/100 stars
  Buy from Supplier

94
Novus Biologicals 4 6 diamidino 2 phenylindole dapi
KEY RESOURCES TABLE
4 6 Diamidino 2 Phenylindole Dapi, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/4 6 diamidino 2 phenylindole dapi/product/Novus Biologicals
Average 94 stars, based on 1 article reviews
4 6 diamidino 2 phenylindole dapi - by Bioz Stars, 2026-03
94/100 stars
  Buy from Supplier

90
ImmunoBioScience Corp fluoroshield mounting medium with 4,6–diamidino–2–phenylindole (dapi)
KEY RESOURCES TABLE
Fluoroshield Mounting Medium With 4,6–Diamidino–2–Phenylindole (Dapi), supplied by ImmunoBioScience Corp, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/fluoroshield mounting medium with 4,6–diamidino–2–phenylindole (dapi)/product/ImmunoBioScience Corp
Average 90 stars, based on 1 article reviews
fluoroshield mounting medium with 4,6–diamidino–2–phenylindole (dapi) - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Beyotime anti-fluorescence quenching mounting solution
KEY RESOURCES TABLE
Anti Fluorescence Quenching Mounting Solution, supplied by Beyotime, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti-fluorescence quenching mounting solution/product/Beyotime
Average 90 stars, based on 1 article reviews
anti-fluorescence quenching mounting solution - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

Image Search Results


a. Left - Representative images of EU (red) and DAPI (Blue) staining, in scr and shp53 cells. Right - quantification of nuclear EU intensity per cell in Scr (101±40; n=383) and shp53 cells (173±76; n=398). EU distribution is divided to tertiaries. The data are representative of three independent experiments with similar results. Statistical analysis was performed using the student’s t-test. b. Left - Representative images of γH2AX (green), EU (red), nuclei (blue) in the same nucleus. Right – Quantification of γH2AX foci in scr (mean foci/cells 1.9; n=383), shp53 (4.1; n=398) and in each tertial of shp53 distribution as shown in A. The mean foci per nucleus in the low (0.5; n=132), mid (3.0; n=132), high (8.7; n=133) tertial. c. Transcription levels quantified using nuclear EU intensity and normalized to scr mean for scr cells (1±0.3; n=708), shp53 cells (1.37±0.3; n=731) and shp53 cells treated with 10-15 μM DRB for 48 hours (1.1±0.4; n=392) or treated with 10ng/ml ActD for 3 hours (1±0.1; n=304). The data are representative of two independent experiments with similar results. Statistical analysis was performed using one-Way Anova test. d. Percentage of nuclei with the indicated number of γH2AX foci for Scr (mean foci/cells 1.9; n=791), shp53 (4.4; n=831), shp53 + 10-15 μM DRB for 48 hours (1.6; n=696) and shp53 + 10ng/ml ActD for 3 hours (1.9; n=769). The data are a summary of two independent experiments. Statistical analysis was performed using Mann Whitney rank-sum test done on the distribution. e. Percentage of cells with the indicated number of micronuclei with the same conditions as d, number of analyzed cells per condition; Scr (n=1126), shp53 (n=1076), shp53 + 10-15 μM DRB for 48 hours (n=945) and shp53 + 10ng/ml ActD for 3 hours (n=934). The Chi-Square test of Independence was performed to compare the distribution of cells with micronuclei between each condition. f. Heatmap representation of log fold changes (log FC) in metabolite levels analyzed using LC-MC in scr, shp53 and shp53 cells treated with 50 μM AUGC for 48 hours, 15 μM DRB for 48 hours or 10ng/ml ActD for 3 hours. The comparisons are shown in the columns (appear at the top of the panel) and include six biological repeats for each condition. In all comparisons the same shp53 data was used. Green - increased metabolite levels compared to the indicated condition. Red - decreased metabolite levels compared to the indicated condition. P-value for each comparison calculated using one-sided t-test and indicated in each box (*p < 0.05, **p < 0.01, the value <0.1 is indicated). g. Hypertranscription fold-change (re-analysis of the TCGA cohort from the study by Zatzman et al.) shown for two groups: WT TP53/MDM2 (mean ± SEM: 2 ± 0.04, n=2273) and TP53-/MDM2+ (mean ± SEM: 2.33 ± 0.03, n=4032). Each circle represents a tumor sample, with the total number of samples per group indicated on the plot. Data are presented as mean ± SEM. Statistical significance was assessed using a non-parametric t-test (Mann-Whitney test) to compare two independent groups, as the data were not normally distributed. P-values less than 0.05 were considered statistically significant (*p < 0.05, **p < 0.01, ***p < 0.001, **p < 0.0001).

Journal: bioRxiv

Article Title: Nucleotide insufficiency induced by p53 deficiency leads to replication stress driving genomic instability

doi: 10.1101/2025.04.17.649416

Figure Lengend Snippet: a. Left - Representative images of EU (red) and DAPI (Blue) staining, in scr and shp53 cells. Right - quantification of nuclear EU intensity per cell in Scr (101±40; n=383) and shp53 cells (173±76; n=398). EU distribution is divided to tertiaries. The data are representative of three independent experiments with similar results. Statistical analysis was performed using the student’s t-test. b. Left - Representative images of γH2AX (green), EU (red), nuclei (blue) in the same nucleus. Right – Quantification of γH2AX foci in scr (mean foci/cells 1.9; n=383), shp53 (4.1; n=398) and in each tertial of shp53 distribution as shown in A. The mean foci per nucleus in the low (0.5; n=132), mid (3.0; n=132), high (8.7; n=133) tertial. c. Transcription levels quantified using nuclear EU intensity and normalized to scr mean for scr cells (1±0.3; n=708), shp53 cells (1.37±0.3; n=731) and shp53 cells treated with 10-15 μM DRB for 48 hours (1.1±0.4; n=392) or treated with 10ng/ml ActD for 3 hours (1±0.1; n=304). The data are representative of two independent experiments with similar results. Statistical analysis was performed using one-Way Anova test. d. Percentage of nuclei with the indicated number of γH2AX foci for Scr (mean foci/cells 1.9; n=791), shp53 (4.4; n=831), shp53 + 10-15 μM DRB for 48 hours (1.6; n=696) and shp53 + 10ng/ml ActD for 3 hours (1.9; n=769). The data are a summary of two independent experiments. Statistical analysis was performed using Mann Whitney rank-sum test done on the distribution. e. Percentage of cells with the indicated number of micronuclei with the same conditions as d, number of analyzed cells per condition; Scr (n=1126), shp53 (n=1076), shp53 + 10-15 μM DRB for 48 hours (n=945) and shp53 + 10ng/ml ActD for 3 hours (n=934). The Chi-Square test of Independence was performed to compare the distribution of cells with micronuclei between each condition. f. Heatmap representation of log fold changes (log FC) in metabolite levels analyzed using LC-MC in scr, shp53 and shp53 cells treated with 50 μM AUGC for 48 hours, 15 μM DRB for 48 hours or 10ng/ml ActD for 3 hours. The comparisons are shown in the columns (appear at the top of the panel) and include six biological repeats for each condition. In all comparisons the same shp53 data was used. Green - increased metabolite levels compared to the indicated condition. Red - decreased metabolite levels compared to the indicated condition. P-value for each comparison calculated using one-sided t-test and indicated in each box (*p < 0.05, **p < 0.01, the value <0.1 is indicated). g. Hypertranscription fold-change (re-analysis of the TCGA cohort from the study by Zatzman et al.) shown for two groups: WT TP53/MDM2 (mean ± SEM: 2 ± 0.04, n=2273) and TP53-/MDM2+ (mean ± SEM: 2.33 ± 0.03, n=4032). Each circle represents a tumor sample, with the total number of samples per group indicated on the plot. Data are presented as mean ± SEM. Statistical significance was assessed using a non-parametric t-test (Mann-Whitney test) to compare two independent groups, as the data were not normally distributed. P-values less than 0.05 were considered statistically significant (*p < 0.05, **p < 0.01, ***p < 0.001, **p < 0.0001).

Article Snippet: Finally, slides were mounted using VECTASHIELD Vibrance Antifade Mounting Medium with DAPI (Vector Laboratories, #H-1800).

Techniques: Staining, MANN-WHITNEY, Comparison

KEY RESOURCES TABLE

Journal: Cell reports

Article Title: G2 arrest primes hematopoietic stem cells for megakaryopoiesis

doi: 10.1016/j.celrep.2024.114388

Figure Lengend Snippet: KEY RESOURCES TABLE

Article Snippet: Fluorescent Mounting Media with DAPI , OriGene , E19-18.

Techniques: Recombinant, Adhesive, Purification, Blocking Assay, Amplification, Random Hexamer Labeling, Reverse Transcription, SYBR Green Assay, Sterility, Imaging, Software